Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) Director Shelley Chu bought 11,111 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average cost of $18.00 per share, with a total value of $199,998.00. Following the purchase, the director directly owned 11,111 shares of the company’s stock, valued at $199,998. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website.
Odyssey Therapeutics Stock Performance
ODTX stock traded up $1.03 during midday trading on Monday, hitting $17.45. The stock had a trading volume of 426,992 shares. Odyssey Therapeutics, Inc. has a 1-year low of $15.35 and a 1-year high of $20.30.
Further Reading
- Five stocks we like better than Odyssey Therapeutics
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
